Structural modification and bioactivity of cyclovirobuxine D

Yaoxue Xuebao

Volumn 39, Issue 6, 2004, Pages 434-438

  Deng, Lan ^a   Huang, Heng ^b   Xu, Ming Xia ^a   Zhou, Shi Qing ^b   Wang, Xing Wen ^b   Lu, Miao ^b   Ren, Fang ^b   Li, Dai Qing ^b  

^a SICHUAN UNIVERSITY   (China)

^b Sichuan Central Inspection Technology Co Ltd   (China)

Author keywords

Antiarrhythmia effects; Cyclovirobuxine D; Endurance lacking oxygen; Structural modification

Indexed keywords

CYCLOVIROBUXINE D;

ARTICLE; CARDIOVASCULAR DISEASE; CHEMICAL MODIFICATION; DRUG ACTIVITY; DRUG DESIGN; DRUG SYNTHESIS;

ANAEROBIC THRESHOLD; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BUXUS; CHLOROFORM; DRUGS, CHINESE HERBAL; FEMALE; MALE; MICE; MOLECULAR STRUCTURE; PLANTS, MEDICINAL; RANDOM ALLOCATION; VENTRICULAR FIBRILLATION;

EID: 7044262882     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Liang BW, Deng CA, Wang XB, et al. Separation and structural research of buxus alkaloids I, II, III, IV [J]. Chin Pharm Bull, 1981,16(4):3-4.
2. Fang TH, Xu HQ, Xu L, et al. Protective action of huangyangning against acute experimental cerebral ischemia in mice [J]. Chin Tradit Herb Drug, 1997,28(7):413-414.
3. Wang YX, Tan YH, Sheng BH. Interaction of cyclovirbuxine-D with some inotropic agents on contractile force of isolated guinea pig myocardium [J]. Chin Pharm J, 1994,29(1):20-22.
4. Liang T, Fang TH, Yao XJ, et al. Pharmacologica research of cyclovirbuxine-D [J]. Pharm J Chin PLA, 2001,17(1):35-37.
5. Liu XJ, Yao MH, Fang TH, et al. Some cardiovascular effects of cyclovirobuxine-D [J]. Acta Pharmacol Sin, 1982,3(2):101-104.
6. Hu SL, Zhou NH, Fan SF. Experimental analysis of the anti-arrhythmic and arrhythmia-inducing actions of cyclovirbuxine D [J]. Acta Pharmacol Sin, 1981,2(2):101-107.